Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord Injury
Recruiting
N/A
Interventional Study
Spinal Cord Injuries (SCI)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 40 (estimated)
- Sponsor
- Milap Sandhu · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate how different doses of acute intermittent hypoxia (AIH) affect lower-limb strength, reaction time, and responsiveness in individuals with spinal cord injury (SCI). The objective is to identify the dose that most effectively improves motor output while also examining parameters that may account for variability in response.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Chronic Spinal Cord Injury (\>6 months)
* Motor incomplete SCI classified as AIS C or D
* Volitional ankle plantarflexion strength in at least one leg
Exclusion Criteria:
* Uncontrolled hypertension (outside 140/90 and 90/60)
* Concurrent medical illness
* Traumatic brain in…
Contacts